Last update 08 May 2025

OTUB1/USP8 dual inhibitor 61(Chinese Academy of Sciences)

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
OTUB1/USP8 dual inhibitor 61( Fudan University), OTUB1/USP8 dual inhibitor 61(Shanghai Jiao Tong University)
Target
OTUB1 x USP8
Action
inhibitors
Mechanism
OTUB1 inhibitors(OTU deubiquitinase, ubiquitin aldehyde binding 1 inhibitors), USP8 inhibitors(ubiquitin specific peptidase 8 inhibitors)
Therapeutic Areas
NeoplasmsRespiratory Diseases
Active Indication
Non-Small Cell Lung Cancer
Inactive Indication-
Originator Organization
Shanghai Jiao Tong UniversityShanghai Jiao Tong UniversityChinese Academy of SciencesChinese Academy of SciencesFudan UniversityFudan University
Active Organization
Fudan UniversityFudan UniversityChinese Academy of SciencesChinese Academy of SciencesShanghai Jiao Tong UniversityShanghai Jiao Tong University
Inactive Organization-
License Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with OTUB1/USP8 dual inhibitor 61(Chinese Academy of Sciences)
Login to view more data
100 Translational Medicine associated with OTUB1/USP8 dual inhibitor 61(Chinese Academy of Sciences)
Login to view more data
100 Patents (Medical) associated with OTUB1/USP8 dual inhibitor 61(Chinese Academy of Sciences)
Login to view more data
1
Literatures (Medical) associated with OTUB1/USP8 dual inhibitor 61(Chinese Academy of Sciences)
27 Oct 2022Journal of Medicinal ChemistryQ1 · MEDICINE
Discovery of Potent OTUB1/USP8 Dual Inhibitors Targeting Proteostasis in Non-Small-Cell Lung Cancer
Q1 · MEDICINE
100 Deals associated with OTUB1/USP8 dual inhibitor 61(Chinese Academy of Sciences)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Non-Small Cell Lung CancerDiscovery
China
Fudan UniversityFudan University
-
Non-Small Cell Lung CancerDiscovery
China
Shanghai Jiao Tong UniversityShanghai Jiao Tong University
-
Non-Small Cell Lung CancerDiscovery
China
Chinese Academy of SciencesChinese Academy of Sciences
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free